To learn more about our three major policy advocacy campaigns, visit our overview HERE. The advocacy fact sheets listed below describe our positions and policy goals on a variety of specific women’s health topics within each campaign.

You can also check out our Health Information Fact Sheets for medically accurate health information about everything from abortion to hormone therapy to osteoporosis.

***

  • Abortion Care and Insurance Coverage
    Abortion is a safe and effective procedure that terminates a pregnancy. Abortion is recognized worldwide as a vital part of women’s health care, women’s ability to plan their families, and women’s economic empowerment. Despite being vital to health and wellbeing, insurance coverage for abortion care in the United States varies based on a woman’s income, where ...
  • Abortion with Pills (Medication Abortion): Policy Issues
    Abortion with pills, also called medication abortion, is a safe and effective way to end a pregnancy by inducing miscarriage. When pregnant people visit the doctor for an abortion using pills, they are most often prescribed two different drugs, to be taken 1-2 days apart. Mifepristone (brand name Mifeprex®) is taken first. Misoprostol (brand name ...
  • Abortion with Pills without a Clinician: The NWHN’s Position on Self-managed Abortion Using FDA-approved Medication
    December 5, 2016, updated February 27, 2018 The concept of abortion is as old as pregnancy itself; women have desired to control their fertility for as long as they have been able to get pregnant. The National Women’s Health Network defends women’s sexual and reproductive health and autonomy against anti-choice threats that seek to undermine access ...
  • Clinical Trials: Greater Inclusion of Women
    The National Women’s Health Network (NWHN) advocates for the greater participation of women and other key groups in clinical trials for all drugs and devices, and particularly for products that are principally marketed and used by women. Age, gender, race, and ethnicity can all have a profound impact on the body’s response to medical products. Differences ...
  • Female Sexual Dysfunction
    The cultural impact and huge profitability of male impotence drugs have created interest in developing a parallel drug treatment for women’s sexual problems. As a result, the pharmaceutical industry has spent more than 15 years working to develop “Female Sexual Dysfunction” (FSD) drugs. The outcome of that effort, however, has been FSD drugs that just don’t ...
  • Female Sexual Dysfunction: Marketing, Politics, and “Pink Viagra”
    Female Sexual Dysfunction The cultural impact and multi-billion dollar profitability of male impotence drugs has accelerated the race to develop and market a parallel drug treatment for women. The overnight success of Viagra, which was developed quite incidentally in an English lab in 1998 when clinical trial volunteers testing a high blood pressure medication reported a ...
  • Generic Drugs
    More than 80 percent of prescriptions filled in the United States are for generic drugs. Women get these prescriptions with the assumption that the drugs they’ve been prescribed are safe and effective. But, right now, women actually have no way of knowing if their generic drugs are safe, or whether they could actually be harmful. This ...
  • Internal (Female) Condoms
    Internal condoms, also called female condoms, are a barrier method of birth control used during intercourse to help prevent pregnancy and sexually transmitted infections (STIs), including HIV. Unlike external, or male, condoms, internal condoms are controlled by the receptive partner. While commonly known as the female condom, the FDA recently issued a proposal to rename the ...
  • Long-Acting Reversible Contraceptives (LARCs): Policy Issues
    In recent years, there has been a surge in the education and promotion of long-acting reversible contraceptives (LARCs). LARCs are reversible birth control methods that are highly effective in preventing pregnancy, last for an extended period of time, and once inserted, work without user action. LARCs include intrauterine devices (IUDs, pictured) and contraceptive implants like ...
  • Menopause Hormone Therapy
    The widespread popularity of menopause hormone therapy is a triumph of marketing over science and advertising over common sense. Drug companies and many health care providers view menopause as a disease to be treated — and hormone therapy is a direct response to that misperception. The National Women’s Health Network (NWHN) works to challenge this ...
  • Osteoporosis: Better Screening, Treatment Policy Issues
    Osteoporosis is a condition, more common in women than men, that causes bones to become brittle and fragile. This makes bones more susceptible to breaking. Bone fractures attributed to osteoporosis affect an estimated 1.5 million people annually and can seriously impact one’s health and quality of life. Some women, particularly those without good access to ...
  • Weight Loss
    Quick-fix weight loss remedies have always been popular, but they’ve gained even more momentum in recent years due to increased attention to the rising rates of obesity in the United States. Anti-obesity drugs are often touted as “miracle products” that yield results with minimal effort. Misleading ads for these products — which appear everywhere from ...